| Industry | 批发和零售业 | ||||||||||||||||||||||||
| Company Introduction | 华东医药股份有限公司是一家医药生产及医药器械制造的企业.公司的主要产品主要为西药及中药药品、医药器械等.1997年1月17日,公司更名为杭州华东医药股份有限公司,公司从单纯的商业企业一举成为集医药产品生产和销售网络于一体的、工商紧密结合的医药生产企业.2010年,公司医药商业继续保持浙江省行业领先地位。 | ||||||||||||||||||||||||
| Main Business | 药品的研发、生产和销售 | ||||||||||||||||||||||||
| Legal Representative | 吕梁 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 陈波 | ||||||||||||||||||||||||
| Solicitors | 浙江天册律师事务所 | ||||||||||||||||||||||||
| Auditors | 天健会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 0571-89903300 | ||||||||||||||||||||||||
| Fax No | 0571-89903300 | ||||||||||||||||||||||||
| Website | www.eastchinapharm.com | ||||||||||||||||||||||||
| hz000963@126.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 27/01/2000 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 1.622 | ||||||||||||||||||||||||
| DPS(RMB)* | ¥ 0.580 | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 11.997 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 59.951B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |